Currencies / MEDP
MEDP: Medpace Holdings Inc
492.09
USD
5.11
(1.05%)
MEDP exchange rate has changed by 1.05% for today. During the day, the instrument was traded at a low of 483.47 and at a high of 494.16.
Follow Medpace Holdings Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
MEDP News
- Cardinal Health Expands At-Home Solutions With New Texas Facility
- MYGN Stock Might Gain on The Lancet Study Backing Precise MRD
- GEHC Stock Gains Following Launch of Revolution Vibe CT Imaging System
- PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq
- MYGN's GeneSight Test Proven Superior to TAU: Stock to Gain?
- Here's Why You Should Hold Cencora Stock in Your Portfolio Now
- Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
- This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Accenture (NYSE:ACN), Academy Sports (NASDAQ:ASO)
- HealthEquity Stock Gains as Q2 Earnings Beat Estimates, Revenues Up Y/Y
- STXS Launches First U.S. Robotic HD Mapping With MAGiC Sweep
- Rothschild Redburn upgrades Iconix Brand stock to Buy on expected demand growth
- Rothschild Redburn downgrades Medpace stock to Neutral on valuation
- IRTC Unveils Positive AMALFI Trial Data Showing Higher AF Detection
- GEHC Launches AI-Powered Vivid Pioneer Cardiac Ultrasound System
- ABT Stock Gains From Navitor's Expanded Indication Approval in Europe
- FDA Identifies ICU Medical's Plum Duo Recall as Serious Type
- Reasons to Retain TransMedics Stock in Your Portfolio for Now
- COO Q3 Earnings Beat, 2025 Sales Outlook Lowered, Stock Down
- Here's Why You Should Add CLOV Stock to Your Portfolio Now
- COR vs. MEDP: Which Stock Is the Better Value Option?
- VEEV Q2 Earnings & Revenues Beat Estimates, Margin Rises, Stock Up
- PAHC Stock Surges on Q4 Earnings & Revenue Beat, Gross Margin Down
- Tracking Terry Smith’s Fundsmith 13F Portfolio – Q2 2025 Update
- PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment
Daily Range
483.47
494.16
Year Range
250.05
501.29
- Previous Close
- 486.98
- Open
- 490.04
- Bid
- 492.09
- Ask
- 492.39
- Low
- 483.47
- High
- 494.16
- Volume
- 833
- Daily Change
- 1.05%
- Month Change
- 3.73%
- 6 Months Change
- 60.11%
- Year Change
- 47.07%
08 September, Monday
19:00
USD
- Act
- $16.01 B
- Fcst
- $11.14 B
- Prev
- $-4.28 B